04 SURGICAL PATHOLOGY (Liver and Gallbladder) - (Dr. Bayotas)
04 SURGICAL PATHOLOGY (Liver and Gallbladder) - (Dr. Bayotas)
04 SURGICAL PATHOLOGY (Liver and Gallbladder) - (Dr. Bayotas)
OUTLINE
MOST COMMON PATTERNS OF INJURY
I. LIVER
II. PATHOLOGIC FINDINGS
III. MOST COMMON PATTERNS OF INJURY HEPATOCELLULAR COMPARTMENT
IV. CLINICAL SYNDROMES o Portal inflammation
V. CHOLESTASIS • Inflammatory cell predominating
VI. NEONATAL CHOLESTASIS ▪ Chr hepatitis
▪ Autoimmune disorder
VII. LIVER NEOPLASMS
(mononuclear)
VIII. METASTASES TO THE LIVER o Interface activity (periportal hepatitis, piecemeal
IX. ACUTE ALLOGRAFT REJECTION necrosis)
X. CHRONIC REJECTION (DUCTOPENIC • Lymphocytes predominating
REJECTION) • Active means ongoing injury
XI. GALL BLADDER o Lobular inflammation
• Lymphocytes distant from the portal
LIVER tract
Keywords: o Vacuolar degeneration (balloon cell change)
• Needle core biopsy • Hydrophic degeneration
o Biopsy is done to monitor disease o Acidophilic bodies
progression (Hepatitis) • Dyskeratotic (pyknotic nuclei)
o Graft vs Host Disease (Evaluation of o Fibrosis
transplant) • Increase of collagen on the portal tract
o Dx suspicious mass • Bridging fibrosis
o Stain use: Trichomes, Iron stain, Prussian • End process is cirrhosis, the division of
blue liver into individual lobules separated by
thick band of fibrous tissue
LEARNING OBJECTIVES o Steatosis
• Deposits of fats at hepatocytes
• >5%-30 Mild
• Recognize the histomorphologic features of
• 30-60% Moderate
conditions affecting the liver and the biliary
• >60% Severe or
tract.
marked
• Describe the pathogenesis of the disease
▪ Due to Rye’s syndrome
process
o Steatohepatitis
• Correlate the morphologic changes with the
• Steatosis with inflammation
clinical presentation of the disease
o Mallory’s hyaline (Mallory bodies)
• Apply basic concepts learned given a case
• Irregular, whorled-like, pink structure
involving disorder of the liver and biliary tract
• Cytoskeleton collapse
• Enumerate important diagnostic procedures
o Megamitochondria
needed to evaluate conditions involving the liver
• Sized like RBC
and biliary tract.
o Iron accumulation
• Interpret results of basic laboratory tests used
• Use Prussian blue to observe
to evaluate disorders of the liver and biliary
PATHOLOGIC FINDINGS
A. Acute Injury
o Widespread edema
o Acute and chronic inflammation
o Necrosis
B. Subacute or chromic injury
o Mononuclear Inflammatory cells
o Necrosis or degeneration
SURGPATH SALMASAN 1 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
HEPATIC FAILURE
o Jaundice
BILIARY COMPARTMENT o Hypoalbuminemia
o Cholestasis o Hyperammonemia
• Accumulation of bile o Palmar erythema
o Bile duct proliferation o Spider angioma
• Increase number bile duct profiles that o Hypogonadism and gynecomastia in men
occurs at each portal tract o Coagulopathy
• The normal ratio is average 1:2 per tract o Hepatic encephalopathy
o Bile duct injury o Hepatorenal syndrome
• Defined as presence of lymphocytes, PORTAL HYPETENSION ASSOCIATED WITH
and vacuolar degeneration: dropped out CIRRHOSIS
epithelial cells o Ascites
o Ductopenia o Splenomegaly
• Recurrent bouts of bile duct injury o Esophageal varices
• Loss of bile duct (chronic damage of the o Hemorrhoids
biliary system) o Caput medusae-abdominal skin
• End stage injury CHOLESTASIS
o Jaundice
VASCULAR COMPARTMENT o Pruritus
o Venulitis (endothelitis) • Bile acid deposit in the skin
• Damage of the endothelium of the o Skin xanthomas
portal/central vein by the inflammatory • Accumulation of fat in macrophages in
cells the skin
• Indication of rejection, graft vs host o Increase alkaline phosphatase
disease o Intestinal malabsorption of fat-soluble vitamin
o Extramedullary hematopoiesis CIRRHOSIS
• Generalized indication of bone marrow o Anorexia
disease o Weight loss
▪ Look for the age of the patient o Weakness
• Fetal, infant o Frank debilitation
(Physiologic) o Progressive liver disease
• Adult (Pathologic) o Portal HPN
o Hepatocellular
• Presence of megakaryocytes
SURGPATH SALMASAN 2 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
SURGPATH SALMASAN 3 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
o Microscopic findings
o Metastatic is more common than primary • Multiple focal nodules without fibrosis
o Benign primary lesion is more common than • Nodular overgrowth of normal appearing
malignant primary lesion hepatocytes
o Metastatic>benign primary lesion> malignant • Large caliber vessels in central stellate
primary lesion scar
▪ Blue area
FOCAL NODULAR HYPERPLASIA (FNH) • Bile ductular proliferation in scar
o Non-neoplastic mass lesion caused by nodular • Absence of bridging fibrosis (differential
overgrowth of hepatocytes in region of altered for cirrhosis)
hepatic blood flow
• Multifocal nodular hyperplasia if it co-
exists with
▪ 20% cases with cavernous
hemangioma
▪ Berry aneurism
▪ Astrocytoma or
▪ Meningioma
o Clinical manifestation
• 80% asymptomatic
• 70-80% solitary
• 80-90 occurs in women of reproductive
age
o Clinical features
• Usually, incidental finding
• Associated with oral contraceptive use
in 50% to 60% of cases
• Rarely associated with abdominal pain,
hepatomegaly, or tenderness
• Associated with extrahepatic vascular
lesions
• Normal alpha-fetoprotein
o Gross findings
• Single subcapsular lesion in in right lobe
• Well-circumscribe lesion
• Average size less than 5cm to 10 cm
SURGPATH SALMASAN 4 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
SURGPATH SALMASAN 5 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
SURGPATH SALMASAN 6 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
SURGPATH SALMASAN 7 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
▪ CAM 5.2, (Pancytokeratin:) Note the numerous mass lesions that are of variable
AE1- AE3, keratin 903 (74%), size. Some of the larger ones demonstrate central
CK7 (90-96%), CK19 (84%), necrosis. The masses are metastases to the liver. The
CK20 (30-70%, more often obstruction from such mases generally elevates
positive in non-peripheral alkaline phos. but not all bile ducts are obstructed, so
tumors), EMA, amylase, PTH- hyperbilirubinemia is typically not present. Also, the
related peptide, p53 (10-94%) transaminases are usually not greatly elevated.
o Negative Stain: AFP
o Molecular: Kras mutations
• Microscopic
o Sinusoids are dilated
o Cholestasis is seen
o Brown pigment (bile)
o Disorganize as seen on the right side of
the slide
- Has a glandular appearance ACUTE ALLOGRAFT REJECTION
- A liver CA may have both HCC and
cholangiolar differentiation • Hepatic Allograft rejection is an injury to the
- DO NOT MAKE BILE, but the cells do make transplanted liver caused by the
mucin, and they can be almost impossible to IMMUNOLOGIC REACTIONS of the HOST
distinguish from mets Adenoca or biopsy or • Three Types of Rejections
FNA 1. Humoral Rejection (Hyperacute/Antibody
Mediated)
o Rare
METASTASES TO THE LIVER o Common in ABO Incompatible Donor
o C4d Immunostains help for the
• The liver and the lungs most common visceral diagnosis
organs involve in the metastases of cancer, for o Keys to the diagnosis of humoral
instance colon cancer, (primary cancer such as: rejection
breast, lungs, pancreas, melanoma, lymphomas, ▪ Graft dysfunction diagnosed
leukemia) by clinical evaluation and
laboratory tests
▪ Liver biopsy with evidence
of active graft damage
suggests humoral rejection
▪ Any pattern of intense
reactivity for C4d
▪ Circulation of anti-donor
specific antibody
2. Acute Rejection (Cellular)
o Most common form
o Occurs usually at 1st– 3rd weeks after
transplantation (7-10 days)
o CELL MEDIATED IMMUNE REACTION
directed to Bile Duct Epithelium and
SURGPATH SALMASAN 8 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
See enlarged copy at the appendix See enlarged copy at the appendix
o The higher the grade the more severe CHRONIC REJECTION (DUCTOPENIC REJECTION)
the cellular rejection
o Loss of bile duct
o This is an immunologic injury to the allograft
o Severe or persistent acute rejection that may
lead to IRREVERSIBLE DAMAGE of the bile
ducts, arteries, terminal hepatic veins
o Centrilobular and Portal Tracts may be affected
GALL BLADDER
o Cholelithiasis (Gallstone)
o Cholesterosis
o Acute Cholecystitis
o Chronic Cholecystitis
o Carcinoma of the Gall Bladder
CHOLELITHIASIS
o This is one of the most common GIT diseases
worldwide affecting F>M
Representative C4d staining in crossmatch-negative o Formation and Risk of Gallstones are due to:
patients. Brown pigment (Humoral Rejection) • Body Weight
A. Capillary staining of C4d in the portal area • Childbearing
showing acute rejection • Estrogens
B. Internal lamina of hepatic artery • Other conditions that cholelithiasis are
C. Acute rejection with portal stroma staining ▪ Hemolysis
surrounding blood vessels or bile ducts ▪ Chron’s disease
D. Faint capsular staining in time zone biopsy ▪ Congenital anomaly
o Key to diagnosis of acute cellular rejection o Gallstone (Stones) – formed based on the
▪ Portal inflammation: heterogenous amount of Cholesterol
infiltrate with activated lymphocytes and o Cholesterol (Mixed Type) (>80% Stones: most
eosinophils common) – Cholesterol, Bile Salts, and
Phospholipids
SURGPATH SALMASAN 9 of 13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
SURGPATH SALMASAN 10 of
13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
SURGPATH SALMASAN 11 of
13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
FREEDOM WALL
REFERENCES
APPENDIX
SURGPATH SALMASAN 12 of
13
SURGICAL PATHOLOGY
(1 SEMESTER)|Liver and Gallbladder Pathology|Dr. Bayotas
ST
SURGPATH SALMASAN 2 of 13